| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.17 | 0.0001 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.24 | 0.0001 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.23 | 0.0002 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0003 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.22 | 0.0006 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0006 |